A report from Disclosure Insight reiterates its Medium Risk rating on Humana HUM.
The D.I. HUM profile states, “Concentrated revenue; acquisition activity; an ongoing internal investigation; and the chairman and CEO positions being held by one person support our opinion of a Medium Risk - Negative Bias rating on HUM. Contracts with the federal government accounted for approximately 75% and 64% of total revenue in 2010 and 1H11, respectively. HUM reported 9 acquisitions for approximately $2 billion, of which at least $1.2 billion was allocated to goodwill."
HUM closed yesterday at $74.22.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in